Dr. John A. Lech
Overview
John Lech, DO, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in the treatment of gastrointestinal malignancies and peritoneal carcinomas.
Dr. Lech is rated as an Advanced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.
His clinical research consists of participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
200 Delafield Road, Pittsburgh, PA 15215
1604 Burtner Road, Natrona Heights, PA 15065
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Sajid M. Peracha, MD, is a medical oncologist at UPMC Hillman Cancer Center, Uniontown. Dr. Peracha is board-certified in medical oncology, hematology, and internal medicine. He received his medical degree from Sind Medical College in Karachi, India. He completed his residency at Woodhull Medical and Mental Health Center in Brooklyn, N.Y., a fellowship at New York Medical College in Valhalla, N.Y., and bone marrow transplant training at the University of Florida in Gainesville, Fla. Dr. Peracha is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Anemia.
UPMC Hillman Cancer Center
Nishant Tageja, MD, is a medical oncologist and hematologist. Dr. Tageja specializes in the treatment of solid tumors such as breast cancer, lung cancer, and colon cancer as well as treatment of all benign and malignant blood disorders including lymphoma, leukemia, and myeloma. Dr. Tageja is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Transplant.
UPMC Hillman Cancer Center, Independence Health System
John K. Waas, DO, is a medical oncologist at UPMC Hillman Cancer Center who practices at Arnold Palmer Medical Oncology at Norwin. Board-certified in medical oncology, Dr. Waas received his medical degree from Philadelphia College of Osteopathic Medicine in Philadelphia. He completed his residency at Lehigh Valley Hospital Center in Allentown, Pa. Dr. Waas is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Protein C Deficiency, Protein S Deficiency, Congenital Antithrombin 3 Deficiency, and Hereditary Resistance to Anti-Vitamin K.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Inflammatory Breast CancerDr. Lech isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Lech isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Lech isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Lech isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency Anemia
- EGFR Positive Lung CancerDr. Lech isAdvanced. Learn about EGFR Positive Lung Cancer.
- Iron Deficiency AnemiaDr. Lech isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Acquired AgranulocytosisDr. Lech isExperienced. Learn about Acquired Agranulocytosis.
- Acute Mountain SicknessDr. Lech isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Lech isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaDr. Lech isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Lech isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Lech isExperienced. Learn about Alveolar Soft Part Sarcoma.